PERBANDINGAN EFEKTIVITAS METHOTREXATE DENGAN PENGGANTI METHOTREXATE PADA PASIEN RHEUMATOID ARTHRITIS ( Studi Pada Pasien Rawat Jalan di RSUD Ulin Banjarmasin)
Abstract Views:
240 times
PDF - FULL TEXT Downloads:
838 times
Abstract
Background :The occurrence of Methotrexate drug shortage at Ulin Banjarmasin Regional Hospital caused a change of Rheumatoid Arthriris (RA) therapy in outpatients, which was originally used Methotrexate turned into using Leflunomide (Arava) and later on Azatioprine (Imuran). It was necessary to analyze the efficacy between Methotrexate with Methotrexate replacement therapy.
Method : Design of the study was anobservational research with retrospective retrieval data.Data analysis using One Way Anova and paired t test. The efficacy of patient therapy RA analyzed from the Disease Activity Score 28 (DAS28) and efficacy persentage.
Result :The results of One Way Anova analysis showed no significant difference between all treatment groups (P> 0.05). From a Post Hoc LSD test it was found that there were significant differences between the initial DAS28Methotrexate with the final DAS28Imuran (P = 0.0034), and between the final DAS28 Arava with the final DAS28 Imuran (P = 0.049). And in the Paired t test there were significant on mean differences between the initial and final DAS28Methotrexate, the initial and final DAS28Arava, and the initial and final DAS28Imuran. Conclusion : There was a difference in the efficacy of Methotrexate with Arava and Imuran with Arava but there was no differences in the efficacy of Methorexate with Imuran in outpatient RA patients in RSUD Ulin Banjarmasin
Downloads
References
2. DiPiro JT, Talbert RL, Yee GC, Gary RM, Barbara GW PM. Pharmacotherapy: A Pathophysiologic Approach, 9e | AccessPharmacy | McGraw-Hill Medical. 2014. https://accesspharmacy.mhmedical.com/book.aspx?bookid=689.
3. Smolen josef S, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. BMJ Publ Gr. 2017. doi:10.1 136/annrheumdis-2016-201715.
4. kemenkes. Formularium Nasional. Indonesia; 2013:35.
5. Divisi Reumatologi DIPDFJP. Rekomendasi Perhimpunan Reumatologi Indonesia Diagnosis dan pengelolaan Artritis Reumatoid. 2014:1-22.
6. Schneider M, Krüger K. Rheumatoide arthritis - Frühdiagnose und krankheitskontrolle. Dtsch Arztebl Int. 2013;110(27-28):477-484. doi:10.3238/arztebl.2013.0477.
7. Afriyanti FN. Tingkat Pengetahuan Lansia Tentang Penyakit Rheumatoid Arthtritis di Panti Sosial Tresna Werdha (PSTW) Budi Mulia 1 Cipayung Jakarta Tahun 2009. 2011.
- Articles published in CALYPTRA are licensed under a Creative Commons Attribution-ShareAlike 4.0 International license. You are free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided you give appropriate credit to the original author(s) and the journal, link to the license, indicate if changes were made, and redistribute any derivative work under the same license.
- Copyright on articles is retained by the respective author(s), without restrictions. A non-exclusive license is granted to CALYPTRA to publish the article and identify itself as its original publisher, along with the commercial right to include the article in a hardcopy issue for sale to libraries and individuals.
- By publishing in CALYPTRA, authors grant any third party the right to use their article to the extent provided by the Creative Commons Attribution-ShareAlike 4.0 International license.
